- By insider

President and CEO of Exact Sciences Corp (30-Year Financial, Insider Trades) Kevin T Conroy (insider trades) sold 30,577 shares of EXAS on 12/01/2020 at an average price of $124.56 a share. The total sale was $3.8 million.

• Warning! GuruFocus has detected 6 Warning Signs with EXAS. Click here to check it out.

• EXAS 15-Year Financial Data

• The intrinsic value of EXAS

• Peter Lynch Chart of EXAS

Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer. Exact Sciences Corp has a market cap of $18.71 billion; its shares were traded at around $124.41 with and P/S ratio of 13.87. Exact Sciences Corp had annual average EBITDA growth of 6.20% over the past five years. GuruFocus has detected 2 severe warning signs with Exact Sciences Corp. .

CEO Recent Trades:

• President and CEO Kevin T Conroy sold 30,577 shares of EXAS stock on 12/01/2020 at the average price of $124.56. The price of the stock has decreased by 0.12% since.

For the complete insider trading history of EXAS, click here

.This article first appeared on GuruFocus.